LZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LegalZoom is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading weakly in pre-market at 5.87, technicals remain bearish, hedge funds are selling, and analysts are split with several target cuts despite some positive comments on AI partnerships and subscription growth. With no strong proprietary buy signal and no fresh catalyst from news, the better move is to wait rather than buy immediately.
LZ is in a bearish technical trend. MACD histogram is below zero and worsening, RSI_6 at 26.162 shows weak momentum, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price is below the pivot at 6.269 and closer to support at 5.761, which suggests downside pressure remains unless it reclaims resistance levels.
Recent analyst commentary from JPMorgan and Jefferies remained constructive, citing a Positive Catalyst Watch, AI partnerships, improving business formation momentum, and a low valuation versus peers. The company also reportedly beat Q1 expectations with stronger transaction and subscription revenue growth, supported by ARPU expansion and premium offerings. No recent negative news event was reported in the last week, which leaves room for a rebound if execution stays solid.
There is no fresh news catalyst in the recent week. Hedge funds are selling aggressively, with selling up sharply over the last quarter, while insiders are neutral. Barclays and Morgan Stanley have negative or cautious stances, citing AI disruption risk, slower growth, and margin pressure from higher investment spending. Pre-market action is slightly negative, and the stock trend model also shows weak forward returns over the next month.
Latest quarter shown in the analyst notes was Q1. The quarter appears to have been an earnings beat, driven by stronger transaction and subscription revenue growth, especially ARPU expansion and higher-value offerings. However, guidance commentary suggests future revenue growth may come more from pricing than volume, and margins may face pressure from increased investment spending through FY26. Overall, growth is improving but not yet strong enough to offset the structural concerns.
Wall Street is mixed. Bullish views from JPMorgan and Jefferies emphasize AI partnerships, improving momentum, and low valuation, while UBS is Neutral and recently cut its target to $7 from $8. Barclays downgraded to Underweight with a $6 target, and Morgan Stanley is also Underweight at $6.50, reflecting concern about AI competition and slower growth. Net-net, pros see a value recovery story, but the cons view is stronger on durability of growth and moat risk.
